12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (TA1045)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 5 March 2025
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen ID6462Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 6 August 2025
Dupilumab for treating severe chronic rhinosinusitis with nasal polyposis (Review of TA648) [ID6480]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 11 September 2025
Benralizumab for previously treated severe nasal polyps [ID1659]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysphagiaStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps [TSID11918]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitisStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Depemokimab for treating chronic rhinosinusitis with nasal polyps [ID6449]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years [ID6537]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
AHEAD implants for external ear prosthesisStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Technologies to support home monitoring of vision change in macular diseaseStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC